Zai Lab (ZLAB) Total Liabilities (2016 - 2026)
Zai Lab (ZLAB) reported Total Liabilities of $433.8 million for Q1 2026, up 19.63% on a YoY basis from $362.6 million in Q1 2025, and down 5.06% sequentially from $456.9 million in Q4 2025.
Zai Lab (ZLAB) Total Liabilities (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 11 years of Total Liabilities data on file, last reported at $433.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 19.63% year-over-year to $433.8 million; the trailing twelve-month figure through Mar 2026 stood at $433.8 million (up 19.63% YoY), and the FY2025 full-year result was $456.9 million, up 32.49% from the prior year.
- Total Liabilities declined to $433.8 million in Q1 2026, from $456.9 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $456.9 million in Q4 2025 to a low of $162.7 million in Q3 2023.
- A 5-year average of $277.0 million and a median of $240.2 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities dropped 24.11% in 2022 and jumped 95.24% in 2024, its largest moves.
- Tracing ZLAB's Total Liabilities over 5 years: stood at $174.5 million in 2022, then jumped by 37.6% to $240.2 million in 2023, then jumped by 43.58% to $344.9 million in 2024, then jumped by 32.49% to $456.9 million in 2025, then declined by 5.06% to $433.8 million in 2026.
- Business Quant data shows ZLAB's Total Liabilities at $433.8 million in Q1 2026, $456.9 million in Q4 2025, and $399.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 433.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433.76 Mn |
| Dec 31, 2025 | 456.88 Mn |
| Sep 30, 2025 | 399.00 Mn |
| Jun 30, 2025 | 372.37 Mn |
| Mar 31, 2025 | 362.58 Mn |
| Dec 31, 2024 | 344.86 Mn |
| Sep 30, 2024 | 317.68 Mn |
| Jun 30, 2024 | 283.19 Mn |
| Mar 31, 2024 | 226.27 Mn |
| Dec 31, 2023 | 240.18 Mn |
| Sep 30, 2023 | 162.72 Mn |
| Jun 30, 2023 | 174.06 Mn |
| Mar 31, 2023 | 168.83 Mn |
| Dec 31, 2022 | 174.55 Mn |
| Sep 30, 2022 | 192.65 Mn |
| Jun 30, 2022 | 206.61 Mn |
| Mar 31, 2022 | 192.91 Mn |
| Dec 31, 2021 | 230.00 Mn |
| Sep 30, 2021 | 140.15 Mn |
| Jun 30, 2021 | 223.52 Mn |